ALPS Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.06M Buy
94,070
+1,454
+2% +$46.7K 0.01% 329
2025
Q4
$3.26M Buy
92,616
+37,782
+69% +$1.34M 0.02% 315
2025
Q3
$1.44M Sell
54,834
-5,795
-10% -$173K 0.01% 441
2025
Q2
$1.61M Buy
+60,629
New +$1.6M 0.01% 398
2024
Q2
Sell
-74,007
Closed -$6.07M 1006
2024
Q1
$6.07M Buy
74,007
+7,630
+11% +$340K 0.04% 213
2023
Q4
$1.24M Sell
66,377
-7,428
-10% -$97.1K 0.01% 418
2023
Q3
$817K Buy
73,805
+418
+0.6% +$5.98K 0.01% 513
2023
Q2
$1.19M Buy
73,387
+21,669
+42% +$454K 0.01% 432
2023
Q1
$861K Sell
51,718
-325
-0.6% -$3.36K 0.01% 501
2022
Q4
$489K Buy
+52,043
New +$232K ﹤0.01% 596
2022
Q2
Sell
-80,540
Closed -$242K 1093
2022
Q1
$242K Sell
80,540
-9,999
-11% -$35.9K ﹤0.01% 792
2021
Q4
$416K Sell
90,539
-5,296
-6% -$29.7K ﹤0.01% 620
2021
Q3
$602K Sell
95,835
-7,030
-7% -$43.4K 0.01% 479
2021
Q2
$616K Sell
102,865
-29,113
-22% -$173K 0.01% 493
2021
Q1
$835K Buy
131,978
+469
+0.4% +$3.3K 0.01% 420
2020
Q4
$740K Buy
131,509
+38,719
+42% +$235K 0.01% 423
2020
Q3
$540K Sell
92,790
-6,237
-6% -$42.9K 0.01% 415
2020
Q2
$714K Sell
99,027
-32,351
-25% -$215K 0.01% 385
2020
Q1
$615K Sell
131,378
-15,322
-10% -$94.2K 0.01% 409
2019
Q4
$1.18M Buy
146,700
+2,681
+2% +$19.5K 0.01% 307
2019
Q3
$991K Sell
144,019
-6,791
-5% -$50.4K 0.01% 314
2019
Q2
$1.25M Sell
150,810
-21,793
-13% -$186K 0.01% 285
2019
Q1
$1.72M Buy
172,603
+7,458
+5% +$62.4K 0.01% 245
2018
Q4
$1.26M Buy
+165,145
New +$1.97M 0.01% 256

Other funds holding VKTX